Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2258745 | chr13:114160910 | T/C | 4.56E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs2258934 | chr13:114167729 | A/C | 3.85E-12 | 178 | 3.32 | 29.57 | 24.23 | KM Plot |
PCPG | rs2258935 | chr13:114167761 | A/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2259702 | chr12:69080728 | T/G | 0.000313 | 172 | 25.87 | 25.35 | 10.3 | KM Plot |
PCPG | rs2259812 | chr13:114137798 | A/C | 6.73E-12 | 172 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2259960 | chr13:114159482 | C/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2259973 | chr13:114158614 | T/C | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260005 | chr13:114158359 | A/G | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260007 | chr13:114158330 | G/A | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260011 | chr13:114157952 | G/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260036 | chr13:114157177 | C/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260080 | chr13:114156093 | C/T | 0.000383 | 178 | 24.23 | 28.95 | 3.7 | KM Plot |
PCPG | rs2260086 | chr13:114155982 | C/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260090 | chr13:114155742 | C/T | 3.98E-12 | 178 | 24.38 | 29.5 | 3.32 | KM Plot |
PCPG | rs2260111 | chr13:114155257 | A/G | 4.44E-12 | 177 | 24.23 | 29.5 | 3.32 | KM Plot |